A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
Hong Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianqiang Cai(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 152
Related Papers
AHR mediates the aflatoxin B1 toxicity associated with hepatocellular carcinoma
|Signal Transduction and Targeted Therapy|2021|122